YHLO's SARS-CoV-2 IgM and IgG CLIA kits, developed during the Wuhan outbreak, have demonstrated excellent performance in a number of hospitals, with advantages of fast speed, high sensitivity and specificity, strong anti-interference ability. With the matching systems——fully automated chemiluminescence analyzer iFlash 1800 / iFlash 3000, YHLO’s SARS-CoV-2 solution is able to offer a safe and efficient way for hospitals and laboratories to aid diagnosis of COVID-19, which is also a valuable supplementary tool for RT-PCR, especially for patients with negative RT-PCR results to rule out false negative.
CopyRight@2019 Shenzhen YHLO Biotech Co., Ltd. rights reserved
Headquarter: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
Int'l Business Office: Rm.501, Building A1, Kexing Science Park, No.15 Keyuan Road, Nanshan District, 518057 Shenzhen, P.R.China
Tel: +86 755 26601910 / Fax: +86 755 26473319 / Email: email@example.com